Global brain health devices market growth is driven by rising prevalence of neurological disorders. Neurological disorders have emerged as a major cause of disability and mortality worldwide. Growing neurological disease burden boosts demand for advanced technologies that enable early diagnosis and effective management of such conditions. Brain health devices aid in neurological screening, monitoring and treatment of various central nervous system diseases. Factors such as rising focus on preventive healthcare, growing geriatric population vulnerable to Alzheimer's and Parkinson's, and increasing healthcare expenditure on brain health can drive the market growth. However, high costs of brain health devices can limit its widespread adoption.
Market Dynamics:
Global brain health devices market growth is primarily driven by rising incidence of neurological disorders coupled with growing geriatric population prone to Alzheimer's and Parkinson's disease. As per WHO Report, neurological conditions accounted for nearly 11% of the global disease burden in 2017. Moreover, rapid aging demographics can expand the target patient pool in the near future. Vast unmet need for advanced diagnostic and monitoring solutions can offer lucrative opportunities for market players. However, high costs of invasive and non-invasive brain health devices can hamper the market growth, especially in price-sensitive developing regions. Ongoing R&D into affordable microchip-based devices can help overcome this challenge. Industry players are focusing on developing portable, multi-functional brain health devices for home care settings to leverage opportunities in remote patient monitoring.
Key features of the study:
- This report provides in-depth analysis of the global brain health devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global brain health devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, Abbott, Nihon Kohden Corporation, Integra LifeSciences, and Natus Medical Incorporated.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global brain health devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain health devices market.
Detailed Segmentation-
- By Device Type
-
- Magnetic Resonance Imaging
- Magneto Encephalogram
- Computed Tomography
- Transcranial Doppler Device
- Others
- By Application
-
- Stroke
- Dementia
- Epilepsy
- Dyslexia
- Others
- By End User
-
- Hospitals
- Specialty Clinics
- Research Institutes
- Home Healthcare
- Others
- By Region
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
-
- Medtronic plc
- Natus Medical Incorporated
- Advanced Brain Monitoring, Inc.
- ElectroCore LLC
- Neuropace, Inc.
- Integra LifeSciences Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Masimo Corporation
- Magstim
- Soterix Medical Inc.
- Cadwell Industries, Inc.
- Cogmedix, Inc.
- Emotiv
- Compumedics Limited
- NeuroSky
- Mindmaze
- Philips Healthcare